Neovasc Tiara(TM) Progress Highlighted at PCR London Valves 2019
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced that its transfemoral trans-septal ("TF/TS") Tiara™ ("Tiara") System was featured today in a tutorial session at the PCR London Valves 2019 meeting,...
2019-11-19 9:00 AM EST
Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany
British Columbia and Mainz, Germany--(Newsfile Corp. - November 12, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that a new milestone has been reached in Germany with the 200th patient implant of the Neovasc Reducer™ (the "Reducer")."Many refractory...
2019-11-12 7:00 AM EST
Neovasc Announces Third Quarter 2019 Financial Results
Recent HighlightsDelivered continued revenue growth for Neovasc ReducerTM ("Reducer")Reducer added to the European Society of Cardiology Practice Guidelines for the treatment of refractory anginaReducer featured at the 40th Annual National Congress of the Italian Society of Interventional CardiologyAnnounced Norman Radow joined the board of directorsGranted a US patent covering Tiara™ ("Tiara") mitral valve replacement deviceVancouver, British Columbia--(Newsfile Corp. - November 7, 2019) -...
2019-11-07 4:05 PM EST
Neovasc Appoints Cardiovascular Industry Veteran Bill Little as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced the appointment of Bill Little as the Company's Chief Operating Officer, reporting directly to the CEO. Mr. Little is an accomplished global...
2019-11-07 7:00 AM EST
Neovasc to Participate in Stifel 2019 Healthcare Conference and Cannacord Genuity 13th Annual MedTech & Diagnostics Forum
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2019) - Neovasc, Inc. (TSX: NASDAQ) (TSX: NVCN) ("Neovasc" or the "Company") a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that Fred Colen, CEO of Neovasc, will be participating in two institutional investor conferences in November. On Wednesday, November 20, Mr. Colen...
2019-11-06 8:30 AM EST
Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the company will be providing an update on its Transfemoral Trans-septal ("TF/TS") Tiara System at the PCR London Valves 2019 meeting, which...
2019-11-05 7:00 AM EST
Neovasc to Submit Full PMA Application for Neovasc Reducer(TM) in 2019
Vancouver, British Columbia--(Newsfile Corp. - November 1, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it intends to submit a full Premarket Approval application ("PMA") to the U.S. Food and Drug Administration ("FDA") for its Neovasc Reducer™...
2019-11-01 8:30 AM EDT
Neovasc to Participate in the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that Fred Colen, CEO of Neovasc, will be participating in the 28th annual Credit Suisse Healthcare Conference in Scottsdale, AZ. Mr. Colen's...
2019-10-30 10:24 AM EDT
Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2019) - Neovasc, Inc. (TSX: NVCN) (NASDAQ: NVCN) ("Neovasc" or the "Company") a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it will report financial results for the quarter ended September 30, 2019 and host a conference call at 4:30 PM Eastern Time on Thursday,...
2019-10-25 7:00 AM EDT
Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Sponsored Session at the 40th Annual National Congress of the Italian Society of Interventional Cardiology
British Columbia and Milan, Italy--(Newsfile Corp. - October 22, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Neovasc Reducer™ ("Reducer") was featured in multiple presentations during the symposium "A Proven Evidence-based therapy when Angina...
2019-10-22 7:00 AM EDT
Neovasc Retains Westwicke, ICR for Integrated Communications Counsel
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced it has retained Westwicke, an ICR company (Westwicke, ICR), for integrated investor and public relations consulting services."As we advance the...
2019-10-16 7:00 AM EDT
Neovasc Announces Notice of US Patent Granted for Tiara(TM) Transcatheter Device for Treatment of Severe Mitral Regurgitation
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,433,952, titled: "PROSTHETIC VALVE FOR AVOIDING OBSTRUCTION...
2019-10-15 7:00 AM EDT
IIROC Trade Resumption - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - September 1, 2017) - Trading resumes in: Company: Neovasc Inc.
2017-09-01 12:33 PM EDT
IIROC Trade Halt - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - September 1, 2017) - The following issues have been halted by IIROC: Company:
2017-09-01 10:08 AM EDT
IIROC Trade Resumption - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - June 16, 2017) - Trading resumes in: Company: Neovasc Inc.
2017-06-16 10:54 AM EDT
IIROC Trade Halt - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - June 16, 2017) - The following issues have been halted by IIROC: Company:
2017-06-16 9:45 AM EDT
IIROC Trade Resumption - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - December 23, 2016) - Trading resumes in: Company: Neovasc Inc.
2016-12-23 12:40 PM EST
IIROC Trade Halt - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - December 23, 2016) - The following issues have been halted by IIROC: Company:
2016-12-23 12:13 PM EST
IIROC Trade Resumption - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - December 20, 2016) - Trading resumes in: Company: Neovasc Inc.
2016-12-20 11:53 AM EST
IIROC Trade Halt - Neovasc Inc.
Toronto, Ontario--(Newsfile Corp. - December 20, 2016) - The following issues have been halted by IIROC: Company:
2016-12-20 11:51 AM EST